Clinical Trial Update: ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating ENAVOgliflozin in patients with severe aortic stenosis after transcatheter aortic valve replacement is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Heart Failure

Drugs mentioned

• Enavogliflozin (enavogliflozin)

Snippet

Sponsor: Duk-Woo Park, MD | Conditions: Aortic Valve Stenosis, Heart Failure | Phase 4 | Status: RECRUITING